Literature DB >> 15117467

Quality of life and functional evaluation after supracricoid partial laryngectomy with cricohyoidoepiglottopexy in Mexican patients.

Kuauhyama Luna-Ortiz1, Ethel R Núñz-Valencia, Mario Tamez-Velarde, Martin Granados-Garcia.   

Abstract

This study assessed the functional results in patients treated primarily through supracricoid partial laryngectomy (SCPL) with cricohyoidoepiglottopexy (CHEP). Fifteen patients with a diagnosis of epidermoid carcinoma of the glottis region admitted to the Instituto Nacional de Cancerología (México) between June 2001 and September 2002 were studied. Three patients were at stage I, five at stage II, six at stage III, and one at stage IV. Both cricoarytenoid units were preserved in 12 patients, and only one in three. Each case was assessed through the clinical grading postoperative aspiration (CGPA) scale, the performance status scale for head and neck cancer (PSS-HNC), and the Karnofsky Performance Scale (KPS). Likewise, voice quality of the patients was assessed regarding tone and intensity using the SpeechViewer version 1 (IBM) and data were obtained with the Cool Edit 2000 software. Twelve patients received phoniatric rehabilitation and three were left without rehabilitation. The average time for decannulation was 12 days and 23 days for removal of the nasogastric catheter. The degree of aspiration was 0 in four patients and one in 11. According to PSS-HNC, the mean for normalcy in the diet was 95 and the mean for those eating in public was 91. Intelligibility reached an average of 90. Karnofsky's assessment was related to the disease and not to the treatment, as it remained at 100 per cent in most patients and was never below 80 per cent. The mean intensity of quality of voice was -18 dB below normal; however, the mean frequency was 243.7 Hz. SCPL and CHEP allows the preservation of the basic function of the larynx; however, a clear alteration in voice occurs after the procedure, although normal frequency is kept when both arytenoids are preserved. Likewise, preservation of both arytenoids shortens the time needed for cannula and feeding catheter removal. PSS-HNC, Karnofsky, and CGPA assessments demonstrated that patients can reach an almost normal bio-psycho-social integration. It is recommended that all patients be subjected to phoniatric rehabilitation.

Entities:  

Mesh:

Year:  2004        PMID: 15117467     DOI: 10.1258/002221504323012030

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  6 in total

Review 1.  Functional outcomes after supracricoid laryngectomy: what do we not know and what do we need to know?

Authors:  Antonio Schindler; Nicole Pizzorni; Francesco Mozzanica; Marco Fantini; Daniela Ginocchio; Andy Bertolin; Erika Crosetti; Giovanni Succo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-06       Impact factor: 2.503

2.  Acoustic analysis of voice in patients treated by reconstructive subtotal laryngectomy. Evaluation and critical review.

Authors:  V Di Nicola; M L Fiorella; D A Spinelli; R Fiorella
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-04       Impact factor: 2.124

3.  The CT evaluation of neoarytenoid soft tissue after an arytenoidectomy during a supracricoid partial laryngectomy.

Authors:  Dong Il Sun; Bum Soo Kim; So Lyung Jung; Kook Jin Ahn; Min Sik Kim
Journal:  Korean J Radiol       Date:  2009 Jan-Feb       Impact factor: 3.500

4.  Speech therapy rehabilitation.

Authors:  M P Luppi; F Nizzoli; G Bergamini; A Ghidini; S Palma
Journal:  Acta Otorhinolaryngol Ital       Date:  2010-10-05       Impact factor: 2.124

5.  Supracricoid laryngectomies: oncological and functional results for 152 patients.

Authors:  C A Leone; P Capasso; G Russo; P D'Errico; P Cutillo; P Orabona
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-10       Impact factor: 2.124

6.  [Supracricoid partial laryngectomy (SCPL) with either cricohyoidoepiglottopexy (CHEP): our experience with 16 cases].

Authors:  Bouchaib Hemmaoui; Mohamed Sahli; Noureddine Errami; Ahmed Rouihi; Mohamed Habib Bahalou; Ilias Benchaifai; Amine Ennouali; Sara Britel; Ismail Nakkabi; Ali Jahidi; Mohamed Zalagh; Saloua Ouaraini; Fouad Benariba
Journal:  Pan Afr Med J       Date:  2017-07-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.